Dr. Tarlow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1111 NE 99th Ave
Suite 301
Portland, OR 97220Phone+1 503-963-2707
Summary
- Internal medicine and gastroenterology trained physician scientist interested endoscopy, GI cancer prevention, digestive diseases, and innovation
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 2018 - 2021
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2017 - 2018
- University of Texas Southwestern Medical CenterInternship, Internal Medicine, 2016 - 2017
- Oregon Health and Science University School of MedicineClass of 2016
- Oregon Health and Science UniversityPhD, Cell, Developmental, and Cancer Biology, 2010 - 2014
- Stanford UniversityBS, Biological Sciences, 2000 - 2004
Certifications & Licensure
- OR State Medical License 2021 - 2025
- CA State Medical License 2018 - 2024
- NC State Medical License 2020 - 2022
- TX State Medical License 2017 - 2021
- AL State Medical License 2020 - 2020
- OK State Medical License 2020 - 2020
- RI State Medical License 2020 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Red CrossBLS
Awards, Honors, & Recognition
- Resko Outstanding Doctoral Dissertation Award Oregon Health & Sciences University, 2014
Clinical Trials
- Empagliflozin in Diuretic Refractory Ascites Start of enrollment: 2021 Nov 15
Roles: Contact, Sub-Investigator
Publications & Presentations
PubMed
- Empagliflozin in Diuretic-Refractory Ascites (DRAin-Em): Results of a Single-Center Feasibility Study.Kelly Hu, Aparna Goel, Branden Tarlow, XingXing Cheng, Sun Kim
Journal of General Internal Medicine. 2024-11-19 - 6 citationsMortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.W Ray Kim, Ajitha Mannalithara, Paul Y Kwo, C Andrew Bonham, Allison Kwong
Hepatology. 2023-03-01 - 19 citationsClinical factors associated with lack of serological response to SARS-CoV-2 mRNA vaccine in liver transplant recipients.George Cholankeril, Alsadiq Al-Hillan, Brandon Tarlow, Daniela Abrams, Jake S Jacobs
Liver Transplantation. 2021-11-01
Press Mentions
- Regenerative Biology: The Versatile and Plastic LiverJune 28th, 2016
Grant Support
- Regenerative capacity of adult liver progenitor cellsNIDDK2012–2017
Professional Memberships
- Member
- AASLDMember
- ASGEMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: